logo
Select company
Select metric
$ -697KNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
44
Sector
50
Industry
53
History
18
$ 1.62Close
$ 1.35 - $ 2.49 52-Week Range
Ticker Information

Ticker

BRTX

Company Name

BIORESTORATIVE THERAPIES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BIORESTORATIVE THERAPIES INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BRTX - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -697K
3/31/2025$ 71.71K
12/31/2024$ -336.49K
9/30/2024$ -984.62K
6/30/2024$ 431.41K
3/31/2024$ -716.58K
12/31/2023$ -826.83K
9/30/2023$ -4.14M
6/30/2023$ -16.15M
3/31/2023$ -17.49M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIORESTORATIVE THERAPIES INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -115.86K.
  • Over the past 5 years, BIORESTORATIVE THERAPIES INC's average CF - Chg. Cash has been $ 166.6K.
  • The median CF - Chg. Cash for BIORESTORATIVE THERAPIES INC during this period was $ -22.07K
  • BIORESTORATIVE THERAPIES INC reached its highest CF - Chg. Cash over the past 5 years at $ 17.96M.
  • The lowest CF - Chg. Cash recorded by BIORESTORATIVE THERAPIES INC in the same timeframe $ -19.35M

BIORESTORATIVE THERAPIES INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
ERNA : ERNEXA THERAPEUTICS INC $ -2.37MLYRA : LYRA THERAPEUTICS INC $ -2.12MLEXX : LEXARIA BIOSCIENCE CORP $ -3.87MVYNE : VYNE THERAPEUTICS INC $ -7.61MAPRE : APREA THERAPEUTICS INC $ -12.17MIBIO : IBIO INC $ -5.63MSXTP : 60 DEGREES PHARMACEUTICALS INC $ 390.33KHCWB : HCW BIOLOGICS INC $ 1.28MICU : SEASTAR MEDICAL HOLDING CORP $ 5.12MPCSA : PROCESSA PHARMACEUTICALS INC $ 1.37M

Similar metrics to CF - Chg. Cash:

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

BRTX - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -19.35M

Minimum

Dec 31, 2022

$ 17.96M

Maximum

Dec 31, 2021

$ 166.6K

Average

$ -22.07K

Median

CF - Chg. Cash Benchmark Analysis

 The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 45.08M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -137M
max$ 138.09M
average$ 1.18M
median$ 116.12K
std$ 45.08M